Merck & Co. announced a lawsuit against the U.S. government to stop the Medicare drug price negotiation program within the Inflation Reduction Act. The pharmaceutical company argued that this program violated the Fifth and First Amendments of the U.S. Constitution. This marked the first attempt by a pharmaceutical company to legally challenge the law.